Deutsche Tageszeitung - Anti-obesity drugs fatten Novo Nordisk profits

Anti-obesity drugs fatten Novo Nordisk profits


Anti-obesity drugs fatten Novo Nordisk profits
Anti-obesity drugs fatten Novo Nordisk profits / Photo: © AFP/File

Danish drugmaker Novo Nordisk reported Thursday a sharp rise in third quarter sales and profits driven by the success of its anti-diabetes and anti-obesity treatments Ozempic and Wegovy.

Change text size:

Net profit rose to 22.5 billion kroner ($3.2 billion) in the period from July to September, a 56 percent increase from the same time last year.

Sales meanwhile rose 29 percent to 58.7 billion kroner.

The results came in slightly better than analyst forecasts of a net profit of around 21.5 billion kroner on sales of 57.7 billion.

Over the first nine months of the year, sales rose by 33 percent to 166.4 billion kroner at constant exchange rates, with a 58 percent jump in sales for Ozempic and a near five-fold increase for Wegovy.

"We are very satisfied with the sales growth in the first nine months of 2023, which is reflecting that more people than ever are benefiting from our innovative diabetes and obesity treatments," chief executive Lars Fruergaard Jorgensen said in a comment.

Ozempic is an injectable anti-diabetic treatment which became wildly popular on social networks for its slimming properties, even though it is not approved for such use.

Novo Nordisk then launched Wegovy, which has the same active ingredient as Ozempic in a different dose, but which was approved by US regulators to treat obesity.

Wegovy is also marketed in Denmark, Norway, the United Kingdom and Germany.

Obesity, which leads to many people developing diabetes, is a growing health problem, with the World Obesity Federation estimating that one in four people could be obese by 2035.

The success of the drugs has led to Novo Nordisk becoming a darling among investors who have driven up the company's share price so much that the company is now Europe's largest by market capitalisation.

Novo Nordisk, which employs nearly 61,400 people in 80 countries, has also become one of the main drivers of the Danish economy.

Over the first six months of the year, GDP of the small Scandinavian country rose by 1.7 percent year-on-year, but without the contribution of the pharmaceutical industry it would have fallen by 0.3 percent, according to the national statistics office.

In its quarterly report, Novo Nordisk maintained its annual outlook of an increase in annual operating profit of between 40 and 46 percent on a rise in sales of between 32 and 38 percent.

(L.Svenson--DTZ)

Featured

Insights Print Group Wins Gold at 2026 GAPP Awards

Insights Print Group has secured a Gold Award in the Coldset Webfed Printing category at the 2026 GAPP Awards. The recognition highlights the company’s technical expertise and commitment to quality within Southern Africa’s printing and packaging industry, marking a significant achievement for its teams and leadership.

BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?

The BingX account showed 85,979.66 SNC as available and 0.00 SNC as frozen. Nevertheless, an employee of BING X, “BingX Ian” (Telegram account: @bingxianw), stated: “We are not having more SNC, you can withdraw 63,355 SNC now” – which means nothing other than that 22,624.66 SNC have simply disappeared at BING X and that BING X was apparently unable to protect these SNC SCANDIC COIN tokens against possible theft by its own staff, or that manipulation to benefit non-existent BING X liquidity has occurred!

Proxymity Unveils MiKaDiv Compliance Solution for Issuers Ahead of New German Tax Regime

Ready from day one of MiKaDiv reporting in January 2027, BZSt-accredited solution will automate shareholder identification, reconciliation and submission.

Prince William and Princess of Wales to Announce Earthshot Prize Winners in Mumbai

Prince William and the Princess of Wales are set to reveal the winners of the sixth Earthshot Prize during an awards ceremony in Mumbai on Tuesday night. The event marks the Princess’s first significant international appearance since her 2024 cancer diagnosis, as the couple joins global leaders to recognize environmental innovations aimed at repairing the planet by 2030.

Change text size: